Clinical studies on activators and inhibitors of fibrinolysis in various internal diseases
Smolenski, W.S.; Bokarew, I.N.; Jerschow, W.I.; Mindlina, G.I.
Folia Haematologica 101(1): 138-141
1974
ISSN/ISBN: 0323-4347 PMID: 4134263 Document Number: 80033
Document emailed within 1 workday
Related Documents
Sobel, B.E. 1987: Fibrinolysis and activators of plasminogen Heart and Lung: the Journal of Critical Care 16(6 Part 2): 775-779Lyutova, L.V.; Andreenko, G.V.; Karabasova, M.A. 1988: Depletion of fibrinolysis activators as a result of continuous stress Folia Haematologica 115(3): 356-360
Kunz, S.; Herschlein, H.J.; Steichele, D.F.; Kidess, E. 1973: Acitivity of physiological inhibitors of blood coagulation and fibrinolysis during pregnancy, labor, and in the puerperium. Immunological studies Die Medizinische Welt 24(33): 1266-1269
Varga, I.; Beregi, E.; Kenéz, B. 1973: Clinical and histopathological studies in oligosymptomatic kidney diseases in internal medicine. II. Hematuria and focal nephritis in adults Orvosi Hetilap 114(3): 131-136
Nagata, K.; Aoyama, R.; Fujita, M.; Isono, Y. 1975: Studies of coagulation and fibrinolysis in kidney diseases in children 1 Nihon Jinzo Gakkai Shi 17(11): 913-928
Mirowski, M.; Wierzbicki, R. 1993: Specific inhibitors of plasminogen activators Postepy Higieny i Medycyny Doswiadczalnej 47(2): 149-159
Li, M.; Youngren, J.F.; Dunaif, A.; Goldfine, I.D.; Maddux, B.A.; Zhang, B.B.; Evans, J.L. 2002: Decreased insulin receptor (IR) autophosphorylation in fibroblasts from patients with PCOS: effects of serine kinase inhibitors and IR activators Journal of Clinical Endocrinology and Metabolism 87(9): 4088-4093
Moiseev, V.S.; Lepakhin, V.K. 1989: Clinical pharmacology and problems of drug therapy in the clinical picture of internal diseases Terapevticheskii Arkhiv 61(8): 6-10
Zahavi, M.; Zahavi, J.; Kakkar, V.V. 1984: Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation Thrombosis and Haemostasis 52(2): 205-209
Breda, R.; Bizzi, B. 1972: Fibrinolysis in internal medicine Minerva Medica 63(88): 4803-4807
Panchenko, V.M.; Vladimirova, A.V.; Pastorova, V.E.; Sukhanova, S.A. 1980: Fibrinolysis and its inhibitors, and platelet aggregation in rheumatism Laboratornoe Delo 11: 671-675
Travis, J.; Salvesen, G. 1983: Control of coagulation and fibrinolysis by plasma proteinase inhibitors Behring Institute Mitteilungen 73: 56-65
Chebotarev, D.F. 1974: Geriatrics in the clinical aspects of internal diseases Terapevticheskii Arkhiv 46(12): 3-10
Nakayama, S.; Koide, H. 1991: Clinical application of proteinase inhibitors to renal diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 49(9): 2109-2114
Musnitskaia, E.N.; Garkavtseva, R.F.; Bochkova, D.N. 1975: Genealogical method in clinical diagnosis of internal diseases Klinicheskaia Meditsina 53(1): 27-31
Tareev, E.M.; Kornev, B.M.; Moiseev, S.V. 1986: Erythema nodosum in the clinical picture of internal diseases Terapevticheskii Arkhiv 58(6): 36-39
Raiskiĭ, V.A. 1970: Psychotropic agents in the clinical aspects of internal diseases Fel'dsher i Akusherka 35(1): 24-29
Nasonova, V.A. 1988: Sjögren's syndrome in the clinical picture of internal diseases Terapevticheskii Arkhiv 60(4): 8-11
Udvarhelyi, A. 1975: Clinical evaluation of Stugeron-Richter in internal diseases Therapia Hungarica 23(3): 111-114
Ohkoshi, M. 1995: Protease inhibitors as anticancer chemotherapy--experimental and clinical studies Gan to Kagaku Ryoho. Cancer and ChemoTherapy 22(4): 417-430